Metabolic Studies of Adrenoleukodystrophy

  • Tadashi Ogino
  • Herbert H. Schaumburg
  • Kunihiko Suzuki
  • Yasuo Kishimoto
  • Ann E. Moser
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 100)


Two series of metabolic studies were prompted by the previous finding that the brain and adrenal tissues of patients with adrenoleukodystrophy, an X-linked genetic disorder,contain unusually long-chain (C22 – C32) fatty acids in cholesterol esters and gangliosides. Postmortem brain tissues from three patients were assayed for activities of the three distinct cholesterol ester hydrolases, using [4-14C]cholesterol oleate, lignocerate and cerotate as the substrates. No deficiency of the crude mitochondrial (pH 4.2), the microsomal (pH 6.0), or the myelin-localized cholesterol ester hydrolases was detected, although the activities of the myelin-localized cholesterol ester hydrolase against cholesteryl lignocerate and cerotate were too low for reliable assays. The activities of the microsomal and myelin-localized hydrolases were actually higher in adrenoleukodystrophy than in controls. Upt le and exclusion by cultured fibroblasts of [1-14C]stearic, [1- C]lignoceric and [1-14C]cerotic acids were also examined. All fatty acids were avidly taken up by the fibroblasts. Stearic acid was excluded from the cells much more rapidly than lignoceric or cerotic acid. No difference was observed in the uptake and exclusion of fatty acids between the controls and adrenoleukodystrophy, except that cells from some cases of adrenoleukodystrophy consistently took up the very long chain fatty acids at greater rates than the control cells. Neither did the distribution of the label among individual lipids reveal differences between the controls and adrenoleukodystrophy, although there were interesting and dramatic differences in the metabolism of lignoceric acid and cerotic acid. Cerotic acid appeared largely inert with 90–95% remaining intact over eight days, while lignoceric acid was mostly incorporated into complex lipids. This series of studies did not uncover the fundamental genetic defect underlying adrenoleukodystrophy.


Stearic Acid Cholesteryl Ester Cholesterol Ester Control Cell Line Cholesteryl Ester Hydrolase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barron, K.D., Bernsohn, J. and Koeppen, A., Esterases of human CNS and PNS and myelin fractions, J. Histochem. Cytochem. 18 (1970) 683.Google Scholar
  2. 2.
    Barron, K.D., Bernsohn, J. and Mitzen, E., Nonspecific esterases of human peripheral nerve and centrum ovale: A comparison and observation on esteratic activity of myelin fractions, J. Neuropath. Exp. Neurol. 31 (1972) 562–582.PubMedCrossRefGoogle Scholar
  3. 3.
    Bernsohn, J., Barron, K.D., Doolin, P.F., Hess, A.R. and Hedrick, M.T., Subcellular localization of rat brain esterases, J. Histochem. Cytochem. 14 (1966) 455–472.PubMedCrossRefGoogle Scholar
  4. 4.
    Burton, B.K. and Nadler, H.L., Schilder’s disease: Abnormal cholesterol retention and accumulation in cultivated fibroblasts, Pediat. Res. 8 (1974) 170–175.Google Scholar
  5. 5.
    Eto, Y. and Suzuki, K., Cholesterol ester metabolism in the brain: Properties and subcellular distribution of cholesterol esterifying enzyme and cholesterol ester hydrolases in adult rat brain, Biochim. Biophys. Acta 239 (1971) 293–311.Google Scholar
  6. 6.
    Eto, Y. and Suzuki, K., Cholesterol ester metabolism in rat brain: A cholesterol ester hydrolase specifically localized in the myelin sheath, J. Biol. Chem. 248 (1973) 1986–1991.PubMedGoogle Scholar
  7. 7.
    Eto, Y. and Suzuki, K., Enzymes of cholesterol ester metabolism in the brain of mutant mice, quaking and jimpy, Exp. Neurol.41(1973) 222–226.PubMedCrossRefGoogle Scholar
  8. 8.
    Eto, Y. and Suzuki, K., Developmental changes of cholesterol ester hydrolases localized in myelin and microsomes of rat brain, J. Neurochem. 20 (1973) 1475–1477.PubMedCrossRefGoogle Scholar
  9. 9.
    Horning, M.G., Williams, E.A. and Horning, E.C., Separation of tissue cholesterol esters and triglycerides by silicic acid chromatography, J. Lipid. Res. 1 (1960) 482–485.PubMedGoogle Scholar
  10. 10.
    Hoshi, M. and Kishimoto, Y., Synthesis of cerebronic acid from lignoceric acid by rat brain preparation. Some properties and distribution of the a-hydroxylation system, J. Biol. Chem. 248 (1973) 4123–4130.PubMedGoogle Scholar
  11. 11.
    Igarashi, M., Belchis, D. and Suzuki, K., Brain gangliosides in adrenoleukodystrophy, J. Neurochem. 27 (1976) 327–328.CrossRefGoogle Scholar
  12. 12.
    Igarashi, M., Schaumburg, H.H., Powers, J., Kishimoto, Y., Kolodny, E. and Suzuki, K., Fatty acid abnormality in adrenoleukodystrophy, J. Neurochem. 26 (1976) 851–860.CrossRefGoogle Scholar
  13. 13.
    Igarashi, M. and Suzuki, K., Effect of exogenous lipids on rat brain cholesterol ester hydrolases, Exp. Neurol. 45 (1974) 549–553.PubMedCrossRefGoogle Scholar
  14. 14.
    Igarashi, M. and Suzuki, K., Effect of exogenous lipids on activities of the rat brain cholesterol ester hydrolase localized in the myelin sheath, J. Neurochem. 27 (1976) 859–866.PubMedCrossRefGoogle Scholar
  15. 15.
    Igarashi, M. and Suzuki, K., Solubilization and characterization of the rat brain cholesterol ester hydrolase localized in the myelin sheath, J. Neurochem. 28 (1977) 729–738.PubMedCrossRefGoogle Scholar
  16. 16.
    Johnson, A.B., Schaumburg, H.H. and Powers, J.M., Histochemical characteristics of the striated inclusions of adrenoleukodvstrophy, J. Histochem. Cytochem. 24 (1976) 725–730.PubMedCrossRefGoogle Scholar
  17. 17.
    Lowry, 0.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265–275.Google Scholar
  18. 18.
    Miller, G.L., Protein determination for large numbers of samples, Analyt. Chem. 31 (1959) 964.Google Scholar
  19. 19.
    Pinter, K.G., Hamilton, J.G. and Muldrey, J.E., A method for rapid microsynthesis of radioactive cholesterol esters, J. Lipid Res. 5 (1964) 273–274.PubMedGoogle Scholar
  20. 20.
    Prabhudesai, A.V., A simple method for the preparation of cholesteryl esters, Lipids 12 (1976) 242–244.CrossRefGoogle Scholar
  21. 21.
    Rumsby, M.G., Riekkinen, P.J. and Arstila, A.V., A critical evaluation of myelin purification. Nonspecific esterase activity associated with central nerve myelin preparations, Brain Res. 24 (1970) 495–516.PubMedCrossRefGoogle Scholar
  22. 22.
    Schaumburg, H.H., Powers, J.M., Raine, C.S., Suzuki, K. and Richardson, E.P., Adrenoleukodystrophy, A clinical and pathological study of 17 cases, Arch. Neurol. 33 (1975) 577–591.CrossRefGoogle Scholar
  23. 23.
    Suzuki, K., Biochemistry of myelin disorders, in the Physiology and Pathology of Axons (Waxman, S.G., ed.), Plenum Press, New York (1977) in press.Google Scholar
  24. 24.
    Yavin, E., Milunsky, A., DeLong, G.R., Nash, A.H. and Kolodny, E.H., Cholesterol metabolism in cultured fibroblasts in adrenoleukodystrophy, Pediat. Res. 10 (1976) 540–543.Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • Tadashi Ogino
    • 1
    • 2
  • Herbert H. Schaumburg
    • 1
    • 2
  • Kunihiko Suzuki
    • 1
    • 2
  • Yasuo Kishimoto
    • 3
    • 4
  • Ann E. Moser
    • 3
    • 4
  1. 1.The Saul R. Korey Department of Neurology, Departments of Neuroscience and PathologyAlbert Einstein College of MedicineBronxUSA
  2. 2.Rose F. Kennedy Center for Research in Mental Retardation and Human DevelopmentAlbert Einstein College of MedicineBronxUSA
  3. 3.The John F. Kennedy InstituteJohns Hopkins University School of MedicineBaltimoreUSA
  4. 4.Departments of Neurology and PediatricsJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations